Monitoring Patients at Risk of Massive Transfusion with Thrombelastography or Thromboelastometry: A Systematic Review
Thrombelastography (TEG) and Thrombelastometry (ROTEM) are viscoelastic whole-blood assays evaluating the haemostatic capacity of blood. These devices are used in algorithms to guide transfusion of haemostatic blood components.
Platelets From Platelet-Rich-Plasma Versus Buffy-Coat-Derived Platelets: What is the Difference
Platelets can be prepared from whole blood either using the platelet-rich-plasma (PRP) method or the buffy-coat method (BC-PC). Yet a third type of platelet component is collected using the apheresis technique.
Treatment of a Hip Capsular Injury in a Professional Soccer Player with Platelet-Rich Plasma and Bone Marrow Aspirate Concentrate Therapy
A series of orthobiologic treatments with platelet-rich plasma and bone marrow aspirate concentrate improved the patient's pain and strength as well as the morphologic appearance of the hip capsule and gluteus minimus tendon on magnetic resonance imaging.
Optimization of Leukocyte Concentration in Platelet-Rich Plasma for the Treatment of Tendinopathy
The optimum composition of PRP for the treatment of tendinopathy has not been directly investigated. Persistent inflammation results in inferior repair with scar tissue. The present study indicates that in an animal model, WBC in PRP contributes to inflammatory cytokine production. Therefore, leukocyte-reduced PRP may be the optimum preparation to stimulate superior healing without scar tissue formation.
Optimization of Leukocyte Concentration in Platelet-Rich Plasma for the Treatment of Tendinopathy
The optimum composition of PRP for the treatment of tendinopathy has not been directly investigated. Persistent inflammation results in inferior repair with scar tissue. The present study indicates that in an animal model, WBC in PRP contributes to inflammatory cytokine production. Therefore, leukocyte-reduced PRP may be the optimum preparation to stimulate superior healing without scar tissue formation.
Comparison of the Therapeutic Effects of Ultrasound-Guided Platelet-Rich Plasma Injection and Dry Needling in Rotator Cuff Disease: A Randomized Controlled Trial
Autologous platelet-rich plasma injections lead to a progressive reduction in the pain and disability when compared to dry needling. This benefit is certainly still present at six months after treatment. These findings suggest that treatment with platelet-rich plasma injections is safe and useful for rotator cuff disease.
Treatment of Athletic Tendonopathy
This article reviews the most widely used treatments for tendinopathy and outlines the literature support for their use.
Autologous Platelet-Rich Plasma for Treating Chronic Wounds
Autologous platelet-rich plasma (PRP) is a treatment that contains fibrin and high concentrations of growth factors and has the potential to aid wound healing.
Use of Autologous Fibrin Glue (Platelet-Poor Plasma) in Abdominal Dermolipectomies
The PPP fostered adhesion between the abdominal dermoadipose flap and the aponeurotic surface only on the first POD and had no influence whatsoever on the incidence of seroma. There are few reports on the use of PPP for plastic surgery, particularly the autologous type, opening up possibilities for further research projects to expand its use.
Preparation of Platelet-Rich Plasma from Small Volume of Whole Blood – A Simplified Approach
This study demonstrates a simple, rapid and inexpensive technique that is useful in obtaining platelets concentrated approximately 11-fold.
The Effect of Salvaged Blood on Coagulation Function as Measured by Thromboelastography
There is concern that salvaged blood has the potential to activate the coagulation system, which might place patients at risk of thrombotic complications.
Risks of Harms Using Antifibrinolytics in Cardiac Surgery: Systematic Review and Network Meta-Analysis of Randomised and Observational Studies
Although meta-analyses of randomised controlled trials were largely inconclusive, inclusion of observational data suggest concerns remain about the safety of aprotinin.